Found: 5
Select item for more details and to access through your institution.
Predictors of continuation for asenapine from real-world data in patients with schizophrenia.
- Published in:
- Annals of General Psychiatry, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12991-024-00512-2
- By:
- Publication type:
- Article
Asenapine add‐on treatment for schizophrenia adults who received antipsychotics: A 52‐week, open‐label study.
- Published in:
- Psychiatry & Clinical Neurosciences, 2023, v. 77, n. 6, p. 365, doi. 10.1111/pcn.13540
- By:
- Publication type:
- Article
INTERACTING OPEN p-BRANES.
- Published in:
- International Journal of Modern Physics A: Particles & Fields; Gravitation; Cosmology; Nuclear Physics, 1995, v. 10, n. 32, p. 4671, doi. 10.1142/S0217751X95002163
- By:
- Publication type:
- Article
Optimal dose for the efficacy of asenapine in patients with schizophrenia: Real‐world data.
- Published in:
- Neuropsychopharmacology Reports, 2024, v. 44, n. 1, p. 234, doi. 10.1002/npr2.12389
- By:
- Publication type:
- Article
Long‐term safety and efficacy of sublingual asenapine for the treatment of schizophrenia: A phase III extension study with follow‐up for 52 weeks (P06125)—Secondary publication.
- Published in:
- Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 328, doi. 10.1002/npr2.12342
- By:
- Publication type:
- Article